CAMP4 Therapeutics
Stock Forecast, Prediction & Price Target
CAMP4 Therapeutics Financial Estimates
CAMP4 Therapeutics Revenue Estimates
CAMP4 Therapeutics EBITDA Estimates
CAMP4 Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 2/28/2021 | 2/28/2022 | 2/28/2023 | 11/30/2025 | 2/28/2026 | 11/30/2026 | 2/28/2027 |
Revenue
% change YoY
| $308.58M N/A | $295.83M -4.13% | $294.94M -0.30% | Avg: $252.01M Low: $248.68M High: $254.50M avg. -14.55% | Avg: $291.96M Low: $281.61M High: $302.31M avg. 15.85% | Avg: $291.96M Low: $288.11M High: $294.85M avg. 0% | Avg: $291.96M Low: $281.61M High: $302.31M avg. 0% |
Net Income
% change YoY
| $-21.15M N/A | $-31.14M -47.22% | $-32.49M -4.30% | Avg: $35.17M Low: $34.56M High: $35.62M avg. 208.25% | Avg: $-5.78M Low: $2.00M High: $-12.89M avg. -116.43% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% |
EBITDA
% change YoY
| $18.13M N/A | $7.49M -58.68% | $276K -96.31% | Avg: $12.89M Low: $12.72M High: $13.02M avg. 4573.63% | Avg: $14.94M Low: $14.41M High: $15.47M avg. 15.85% | Avg: $14.94M Low: $14.74M High: $15.09M avg. 0% | Avg: $14.94M Low: $14.41M High: $15.47M avg. 0% |
EPS
% change YoY
| -$0.62 N/A | -$0.88 -41.93% | -$0.9 -2.27% | Avg: $0.95 Low: $0.93 High: $0.96 avg. 205.55% | Avg: -$0.16 Low: $0.06 High: -$0.36 avg. -116.84% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% |
Operating Expenses
% change YoY
| $125.87M N/A | $134.75M 7.05% | $129.11M -4.18% | Avg: $77.19M Low: $76.17M High: $77.95M avg. -40.20% | Avg: $89.43M Low: $86.26M High: $92.60M avg. 15.85% | Avg: $89.43M Low: $88.25M High: $90.31M avg. 0% | Avg: $89.43M Low: $86.26M High: $92.60M avg. 0% |
FAQ
What is CAMP4 Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 22.95% in 2025-2027.
We have gathered data from 1 analysts. Their low estimate is 34.56M, average is 35.17M and high is 35.62M.
What is CAMP4 Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 0.32% in 2025-2027.
We have gathered data from 1 analysts. Their low revenue estimate is $248.68M, average is $252.01M and high is $254.50M.
What is CAMP4 Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 22.17% in 2025-2027.
We have gathered data from 1 analysts. Their low earnings per share estimate is $0.93, average is $0.95 and high is $0.96.
What is the best performing analyst?
In the last twelve months analysts have been covering CAMP4 Therapeutics stock. The most successful analyst is Edward Tenthoff.